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ORIGINAL ARTICLE – GASTROINTESTINAL ONCOLOGY
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ABSTRACT
Background. This study aimed to evaluate the influence
that serum levels of vitamin B12, folate, and homocysteine
have on the development of short-term postoperative cog-
nitive decline in the elderly surgical oncology patient.
Methods. This study was part of a prospective cohort
study focused on postoperative cognitive outcomes for
patients 65 years of age or older undergoing surgery for a
solid malignancy. Postoperative cognitive decline was
defined as the change in the combined results of the Ruff
Figural Fluency Test and the Trail-Making Test Parts A
and B. Patients with the highest change in scores 2 weeks
postoperatively compared with baseline were considered to
be patients with cognitive decline. Patients with the lowest
change were considered to be patients without cognitive
decline. To analyze the effect of vitamin levels on the
changes in postoperative cognitive scores, uni- and multi-
variate logistic regression analysis were performed.
Results. The study enrolled 61 patients with and 59
patients without postoperative cognitive decline. Hyper-
homocysteinemia was present in 14.2% of the patients.
Patients with postoperative cognitive decline more often
had hyperhomocysteinemia (27.9 vs 10.2%).
Hyperhomocysteinemia was associated with a higher
chance for the development of postoperative cognitive
decline (odds ratioadjusted, 11.9; 95% confidence interval,
2.4–59.4). Preoperative vitamin B12 or folate deficiency
were not associated with the development of postoperative
cognitive decline.
Conclusion. Preoperative hyperhomocysteinemia is asso-
ciated with the development of postoperative cognitive
decline. The presence of preoperative hyperhomocys-
teinemia could be an indicator for an increased risk of
postoperative cognitive decline developing in the elderly.
Postoperative cognitive impairment, a decline in cog-
nitive function for weeks or months after surgery, is a
frequently reported complication.1,2 It is reported for
25–30% of elderly patients within the first 2 weeks and for
10–15% of patients 3 months after major surgery.3,4
In the past, survival was the main goal of cancer treatment.
Currently, as survival has improved due to better and more
advanced anesthetic and surgical techniques, quality of life
after surgical cancer treatment is becoming an increasingly
important issue, and preventing postoperative cognitive
decline could contribute to improving quality of life.1
For patients with a cancer diagnosis, malnutrition is a
common condition that can affect as many as 50–85% of
patients, depending on the type of cancer.1,2 Among mal-
nourished patients, 40% experience postoperative
complications, whereas only 15% of patients without
malnutrition experience postoperative complications.5,6
One aspect of malnutrition is a possible vitamin defi-
ciency. Decreased serum levels of vitamin B12 and folate
lead to an elevated level of homocysteine due to decreased
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conversion of homocysteine to methionine. Methionine is
necessary for maintaining the integrity of the nervous
system (Fig. 1).7,8
Vitamin B12 deficiency is reported to occur in 10–15%
of individuals older than 60 years.9 Folate deficiency is
prevalent in 30–35% of the elderly,10 and hyperhomocys-
teinemia is present in 29–70% of the older population.10–12
An even greater prevalence of these changes in vitamin
status can be expected in elderly cancer patients due to the
increased metabolic activity of the tumor, a catabolic state,
or reduced food intake.13 These metabolic changes could
contribute to an increased vulnerability of the nervous
system to the inflammatory response to surgery, leading to
the development of postoperative cognitive changes.
This study tested the hypothesis that patients with short-
term postoperative cognitive decline more often have lower
levels of serum vitamin B12 and folate and higher levels of




This study was a subanalysis of data from the ongoing
prospective observational PICNIC study. This study con-
cerning postoperative cognitive changes in elderly cancer
patients started in April 2010 and aimed to assess the
incidence of postoperative cognitive changes, its determi-
nants, and its effects on quality of life. The study was
conducted at the University Medical Center Groningen
(Groningen, the Netherlands). The research protocol was
approved by the Medical Ethical Committee of this hos-
pital (trial no. NL45602.042.14).
Patients 65 years or age or older were enrolled in this study
when they were considered eligible for surgical removal of a
malignant solid tumor in the gynecologic tract, digestive tract,
soft tissue/skin, or other organs under general, regional, or
local anesthesia. The exclusion criteria ruled out any physical
condition potentially hampering compliance with the study
protocol including insufficient understanding of Dutch lan-
guage, preexisting cognitive impairment, and a recent history
of stroke with severe loss of cognition and function. All par-
ticipating patients gave informed consent.
Preoperatively data about basic patient characteristics
and medical history were obtained, and blood samples were
acquired to determine biochemical parameters. Before
surgery, the Groningen Frailty Index (GFI), the Mini
Mental State Examination (MMSE), and the Charlson
Comorbidity Index (CCI) were performed.14–16
To assess pre- and postoperative cognitive function,
neuropsychological tests were conducted at baseline (be-
fore surgery) and 2 weeks postoperatively. The Ruff’s
Figural Fluency Test (RFFT, parts 1–5) was used to mea-
sure strategic reasoning, planning, and ability to ignore
distractors, which involved the number of unique patterns
drawn during each part of the RFFT.17,18 Additionally, the
number of seconds it took to complete the Trail-Making
Test (TMT A and B) was used to measure information-
processing speed.19,20
The preoperative tests were conducted either in the
outpatient department, at the patients home during a visit,
or after admission to the hospital the day before surgery.
The postoperative tests were conducted 14 days after sur-
gery, either during the admission or at the patient’s home
after discharge. All tests were performed by a trained
research nurse or research student. For an overview of the
assessments, see Table 1.
FIG. 1 Overview of factors contributing to the development of postoperative cognitive decline
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Current Analysis
The current analysis was focused on the relationship of
serum vitamin B12, homocysteine, and folate to the
development of short-term postoperative cognitive
changes.
Postoperative cognitive decline, as measured with the
RFFT and TMT parts A and B, was defined as the stan-
dardized change over time. For each cognitive test, the raw
test scores were standardized according to the preoperative
standard deviation of the scores for the complete patient
population of the PICNIC study. For each patient, the
standardized Z scores for the different tests were averaged
into a combined Z score. This was done for both the pre-
and postoperative cognitive function tests. The preopera-
tive Z score was subtracted from the postoperative Z score
to create a standardized difference between the pre- and
postoperative tests for each patient.
Patients selected from the PICNIC study cohort partic-
ipated during the period between April 2010 and January
2014. The scores on the pre- and postoperative cognitive
tests, RFFT and TMT parts A and part B, were used to
divide the patients into two groups. From the 203 patients
in the PICNIC study cohort, those with the largest positive
standardized difference in scores 2 weeks postoperatively
compared with the preoperative scores (i.e., the patients
with the greatest decline in cognitive function) were con-
sidered to be patients with cognitive decline, whereas the
patients with the largest negative standardized difference in
scores were considered to be patients without cognitive
decline (Fig. 2).
This analysis used the information registered in the
PICNIC database. Vitamin status was assessed with serum
vitamin B12, serum folate, and serum homocysteine in
samples collected before surgery. Serum vitamin B12 and
folate levels were analyzed using the enzyme-linked
immunosorbent assay (ELISA) method (Cloud-Clone
Corp, Houston, TX, USA). The standard curve had a
highest concentration of 2 ng/ml. Samples were diluted 1:1
in 0.1% BSA/PBS buffer. Serum homocysteine level was
analyzed with the enzyme-cycling method. Cutoff points of
200 pg/ml for vitamin B12 and 1.0 ng/ml for folate were
used to define deficiency. For serum homocysteine a serum
level of 15 lmol/L or higher was used to define
hyperhomocysteinemia.
Statistical Analysis
Power Analysis Sample size calculation was performed
on the basis of an expected 20% increase of vitamin B12
TABLE 1 Overview of assessments in the PICNIC study




Body weight X X
Length X
Educational level X
Type of surgery X
Goal of surgery X
Cognitive tests
Ruff figural fluency test X X
Trail-making test part A X X
Trail-making test part B X X
Screening instruments
Groningen frailty indexa X X X
Mini mental state examination X
Charlson comorbidity index X
Biochemical parameters
Serum homocysteine X
Serum vitamin B12 X
Serum folate X
aAt time of inclusion or before surgery
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deficiency in patients with postoperative cognitive decline.
A 15% vitamin B12 deficiency has been observed in
elderly surgical cancer patients without postoperative
cognitive changes.9 In elderly surgical cancer patients
with postoperative cognitive decline, we expected a
vitamin B12 deficiency of about 35%. Based on these
differences, a sample size calculation was performed
showing that a sample size of 60 elderly surgical cancer
patients with postoperative cognitive decline and 60 elderly
surgical cancer patients without postoperative cognitive
decline achieved 80% power, given an alpha of 0.05, to
show an association between vitamin B12 deficiency and
postoperative cognitive decline. Based on the literature, we
expected a 15% increase of folate deficiency and a 13%
increase of hyperhomocysteinemia in patients with
postoperative cognitive decline.10,21
Statistical Analyses To describe baseline characteristics
and the differences between patients with and without
postoperative cognitive changes, the Chi square test was
used for categorical variables, and the Mann–Whitney
U test was used for continuous variables. For statistical
analysis, the serum vitamin levels were dichotomized
respectively into the presence or absence of vitamin B12,
folate deficiency, and hyperhomocysteinemia. To
determine the influence of serum vitamin B12, folate, and
homocysteine on the development of postoperative
cognitive decline, logistic regression analysis was
performed for each vitamin separately, and odds ratios
(ORs) with 95% confidence intervals (CIs) were estimated.
To adjust for potential confounders, the baseline variables
that differed significantly (P\ 0.10) between patients with
and without postoperative cognitive decline were included
in the logistic regression analyses. Data analysis was
performed using IBM SPSS Statistics version 22. All




The study enrolled 120 patients (61 with and 59 without
postoperative cognitive decline). The patients with cogni-
tive decline were significantly older than the patients
without changes in postoperative cognition (Table 2). Also,
the patients with cognitive decline more often had a CCI
score of 4 or higher and a GFI score of 4 or higher, scored
lower on the MMSE, and more frequently had an educa-
tional level of primary school or lower (Table 2). Among
the 61 patients with cognitive decline, 5 (8.2%) had post-
operative delirium.
The mean standardized difference between the pre- and
postoperative tests for the patients with postoperative
cognitive decline was 0.16, compared with –0.31 for the
patients without postoperative cognitive decline.
Vitamin Levels and Postoperative Cognitive Decline
Hyperhomocysteinemia was present in 14.2% of the
patients. Vitamin B12 deficiency was present in 12.5% and
folate deficiency in 89.2% of the patients. Hyperhomo-
cysteinemia was more often present in the patients with
postoperative cognitive decline (27.9%) than in the patients
without postoperative cognitive changes (10.2%)
(Table 3). The patients with hyperhomocysteinemia more
often experienced comorbid conditions (Table 3). Vitamin
B12 or folate deficiency did not differ between the patients
with and without postoperative cognitive changes. The
majority of the patients with and without postoperative
cognitive changes had folate deficiency (Table 2).
Logistic regression analysis showed that hyperhomo-
cysteinemia (ORadjusted, 11.95; 95% CI 2.41–59.35) was
PICNIC cohort study

















N = 61 N = 59
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N = 263
Composite Z scores calculated
FIG. 2 Patient selection
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associated with a higher chance for the development of
postoperative cognitive decline (Table 4). Vitamin B12 or
folate deficiency was not associated with the development
of short-term postoperative cognitive decline. The effect of
the serum vitamin levels on the development of postoper-
ative cognitive changes was adjusted by estimation for age,
MMSE score, and GFI score.
DISCUSSION
Preoperative hyperhomocysteinemia, corrected for age,
GFI score, and MMSE score, was associated with the
development of short-term postoperative cognitive decline.
Neither vitamin B12 nor folate deficiency was related to
the development of postoperative cognitive changes.
In this study we focused on the effects of vitamin B12,
folate, and homocysteine, and on the combined effect of
each different vitamin in combination with other known
risk factors on the development of postoperative cognitive
decline. When those other risk factors such as age, worse
performance on MMSE, and frailty were also present, an
increased risk for the development of postoperative cog-
nitive decline in patients with hyperhomocysteinemia was
observed.
The development of postoperative cognitive decline is a
multifactorial process. Neuro-inflammation is considered
to be a possible causative factor (Fig. 1).4,22,23 Further-
more, age and preoperative cognitive impairment are
known risk factors.1,3,24
TABLE 2 Baseline characteristics of the total study population versus the patients with and without postoperative cognitive decline
Variables Total population
(n = 120)
Patients without postoperative cognitive
decline (n = 59)
Patients with postoperative cognitive
decline (n = 61)
Median age: years (range) 72.9 (65.0–89.0) 69.1 (65.0–81.0) 76.0 (66.0–89.0)
Gender: n (%)
Male 59 (49.2) 30 (50.8) 29 (47.5)
Female 61 (50.8) 29 (49.2) 32 (52.5)
CCI: n (%)a
\ 4 75 (63.6) 42 (72.4) 33 (55.0)
C 4 43 (36.4) 16 (27.6) 27 (45.0)
GFI: n (%)a
\ 4 75 (63.0) 42 (71.2) 33 (55.0)
C 4 44 (37.0) 17 (28.8) 27 (45.0)
Median MMSE (range) 28.1 (20.0–30.0) 29.0 (26.0–30.0) 27.2 (20.0–30.0)
Educational level: n (%)b
B Primary school 16 (13.4) 4 (6.8) 12 (20.0)




443.4 (57.0–1688.0) 459.0 (57.0–1688.0) 428.0 (66.0–1645.0)
Vitamin B12 deficiency:
n (%)c
15 (12.5) 9 (15.3) 6 (9.8)
Serum folate: n (%) 0.6 (0.1–9.8) 0.4 (0.1–5.2) 0.7 (0.1–9.8)
Folate deficiency: n (%)d 107 (89.2) 55 (93.2) 52 (85.2)
Serum homocysteine
(range)
10.1 (0–166.3) 7.2 (0.1–113.0) 13.1 (0.9–166.3)
Hyperhomocysteinemia:
n (%)e
17 (14.2) 4 (6.8) 13 (21.7)
CCI Charlson comorbidity index, GFI Groningen frailty index, MMSE, mini mental state examination
a1 missing patient in the group patients with postoperative cognitive decline
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In many cases, the condition remains unrecognized until
patients or relatives notice difficulties related to the post-
operative cognitive decline weeks or months after surgery.
Although cognitive decline usually is reversible, it may be
long-lasting and can have consequences with regard to
quality of life.1,2 Although postoperative cognitive decline
is a specific condition, distinguishing it from dementia
syndromes remains difficult due to the similarity in clinical
symptoms.
The current literature shows no consensus on the defi-
nition of postoperative cognitive decline and the use of
specific neuropsychological tests for the diagnosis. The
cognitive domains of the neuropsychological tests (strate-
gic reasoning, planning, and the availability to ignore
distractors in the RFFT, and the information processing
speed for TMT parts A and B) are similar to those in other
studies on postoperative cognitive decline.1 Practice effects
for neuropsychological testing of healthy volunteers and
the elderly have been described in the literature.25–27 With
these practice effects taken into account, the decrease in
performance on the postoperative tests becomes even more
remarkable and indicates an actual decline in cognitive
functioning.
In this study, postoperative cognitive decline was
defined with the use of Z scores based on the method
introduced by the International Study of Postoperative
Cognitive Dysfunction.3 The patients with the largest
positive standardized difference between the scores on the
different cognitive tests 2 weeks postoperatively and the
preoperative scores were considered to be patients with
cognitive decline. With use of this method, the difference
between pre- and postoperative cognitive functioning
becomes apparent, and postoperative cognitive decline can
be identified.
The relationship between hyperhomocysteinemia and
the development of cognitive decline has been reported
previously in the literature.21,28–30 Next to the development
of cognitive decline, hyperhomocysteineima is associated
with several other conditions such as stroke, atherosclero-
sis, ischemic heart diseases, and the development of
osteoporosis in women.31–34 The effect of hyperhomocys-
teinemia on the specific development of postoperative
cognitive changes has not been described previously.
In our study, the association between hyperhomocys-
teinemia and the development of postoperative cognitive
decline was much stronger than the effect of hyperhomo-
cysteinemia on cognitive changes in general, as described
in the literature.29,30,33,35,36 The incidence of hyperhomo-
cysteinemia in our population was lower than that reported
in the literature. The causes of hyperhomocysteinemia can
be primarily genetic, such as MTHFR 677C[T poly-
morphism, or acquired due to underlying diseases,
medication, or lifestyle.31,36,37 Next to folate and vitamin
B12 deficiency, renal dysfunction, unfavorable lipid pro-
files, increasing age and male sex are associated with
hyperhomocysteinemia.31,36 Furthermore, smoking,
increased coffee consumption, and probably increased
alcohol consumption influences serum homocysteine
levels.31,32
In our reasonably fit study population, a relatively small
number of patients experienced conditions such as renal
dysfunction (Table 3). The relative health of our popula-
tion could be an explanation for the lower incidence of
hyperhomocysteinemia. The presence of hyperhomocys-
teinemia indicates a diminished conversion of
homocysteine to methionine.7,8 This leads to insufficient
donation of methyl groups to methyl acceptors in the ner-
vous system. Methyl is a necessary compound for
TABLE 3 Differences in patient characteristics and comorbid conditions between patients with and without hyperhomocysteinemia
Variables Patients with hyperhomocysteinemia (n = 17) n (%) Patients without hyperhomocysteinemia (n = 103) n (%)
POCD 13 (76.5) 47 (46.5)
Median age: years (range) 73.6 (66.0–87.0) 72.8 (65.0–89.0)
Male gender 13 (76.5) 44 (43.6)
GFI C 4 6 (35.3) 36 (36.0)
MMSE (range) 28.3 (25.0–30.0) 28.1 (20.0–30.0)
CCI C 4 12 (70.6) 30 (30.3)
Comorbidities
Cerebrovascular accident 1 (5.9) 5 (5.1)
Diabetes mellitus 6 (35.3) 10 (10.1)
Cardiac failure 6 (35.3) 12 (12.1)
Impairment of renal function 2 (11.8) 9 (9.1)
POCD postoperative cognitive dysfunction, GFI Groningen frailty index, CCI Charlson comorbidity index
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maintaining the integrity of the nervous system including
myelin, a number of neurotransmitters, and membrane
phospholipids.7 Furthermore, elevated homocysteine levels
may cause demyelination of cranial and peripheral nerves
and of white matter in the brain.38 Although these effects
may not be clinically manifest, it might make the brain
more susceptible to further cognitive decline. The effect of
neuroinflammation after surgery could possibly lead to an
accelerated development of cognitive decline in an already
susceptible brain. Hyperhomocysteinemia therefore serves
as a marker of the vulnerable brain.
The number of patients experiencing vitamin B12 of
folate deficiency is in accordance with the litera-
ture.10,24,39,40 In this study, vitamin B12 and folate
deficiency were not related to the development of postop-
erative cognitive decline. One possible explanation is that
vitamin B12 or folate deficiency separately does not
influence the development of postoperative cognitive
changes but that the combined effect could have an impact
on the development of postoperative cognitive decline.
This study was the first to analyze the influence of serum
vitamin and serum homocysteine levels on the develop-
ment of postoperative cognitive changes. Current literature
describing the influence of vitamin levels on cognitive
decline focuses on cognitive impairment in general. Fur-
thermore, in this study, we analyzed the effects of vitamin
B12, folate, and homocysteine separately. Given the known
strong association of age, preoperative frailty, and preop-
erative cognitive impairment with the development of
postoperative decline, for each vitamin, we calculated
adjusted ORs in addition to unadjusted ORs. In this way,
we were able to present the independent effect of serum
vitamin and hyperhomocysteinemia on postoperative cog-
nitive decline.
In the future, consensus should be reached on the
diagnostic criteria for postoperative cognitive decline
based on standardized cognitive function tests. Other
considerations for future research are further investigation
of the relationship between hyperhomocysteinemia and the
development of postoperative cognitive decline, the effect
of vitamin supplementation on hyperhomocysteinemia, and
eventually, the effect of nutritional interventions in patients
with hyperhomocysteinemia on the development of post-
operative cognitive changes.
CONCLUSION
This study showed that the presence of preoperative
hyperhomocysteinemia is associated with the development
of mild postoperative decline in relatively healthy surgical
oncology patients. The effect of preoperative hyperhomo-
cysteinemia on the development of cognitive decline was
sustained when adjusted for age, frailty, and preoperative
cognitive functioning. Serum levels of vitamin B12 or
folate were not associated with the development of post-
operative cognitive changes.
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